U-Net benign prostatic hyperplasia-trained deep learning model for prostate ultrasound image segmentation in prostate cancer

基于U-Net良性前列腺增生训练的深度学习模型用于前列腺癌的前列腺超声图像分割

阅读:1

Abstract

BACKGROUND: Prostate cancer (PCa) remains a leading cause of male morbidity and mortality globally, where transrectal ultrasound (TRUS) serves as the cornerstone imaging modality for diagnosis and therapeutic guidance. However, automated segmentation of prostatic anatomy in TRUS is persistently hindered by technical constraints. This study aimed to develop prostate segmentation model trained by deep learning from ultrasound images of patients with benign prostatic hyperplasia (BPH) and to verify if the developed model can be applied for the ultrasound image segmentation of patients with PCa. METHODS: A total of 370 and 68 prostate ultrasound images were collected from 260 BPH patients and 62 PCa patients, respectively. U-Net, LinkNet and PSPNet neural network were used to train segmentation model. The Dice coefficients of the model segmentation for test set comprising BPH and PCa images were calculated. Two independent-sample t-tests were used to compare the Dice coefficients. RESULTS: The study demonstrated significant radiomic differences between PCa and BPH in ultrasound imaging, with least absolute shrinkage and selection operator (LASSO) regression identifying 9 discriminative features including shape and texture parameters. The U-Net model achieved superior segmentation performance with a peak Intersection over Union (IoU) of 0.9602 and maintained robustness across resolutions. The independent-sample t-test proved that the two groups did not differ significantly (P>0.05). Four post-segmentation image-processing methods all proved that the model was effective (P>0.05). CONCLUSIONS: We proved that prostatic segmentation model trained on ultrasound images of BPH could be applied in PCa.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。